Gujarat Terce Laboratories Ltd Share Price

Pharmaceuticals

BSE: 524314 Small Cap ISIN: INE499G01013

As on 18 November 2025 at 23:52 IST

₹44.30

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

-9.59%

Over 6 Months

-23.22%

Over 1 Year

-45.04%

Over 3 Years

158.31%

Gujarat Terce Laboratories Ltd Summary

Close ₹44.30

Open ₹45.10

High ₹46.58

Low ₹44.06

Volume 11,993

Net Turnover (in Cr) ₹0.053

52Wk High ₹92.22

52Wk Low ₹37.20

52Wk High / Low

37.20

92.22

Gujarat Terce Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹32.87

EPS (TTM) -

Book Value (BV) 10.09

Div. Yield -

P/E (TTM) -32.10

Price/Book Value 4.39

Delivery % 82.91 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 7.40

EV to Sales 0.91

PEG Ratio -

ROA -9.05

ROE -

Debt-Equity 0.35

Net Profit Margin -1.95

Operating Profit Margin 8.37

Gujarat Terce Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	50.50	48.30	47.14	40.44	25.98
Total Expenses	47.11	47.75	50.03	39.69	28.51
Profit Before Tax	3.39	0.54	-2.89	0.75	-2.53
Profit After Tax	-0.98	0.24	-1.67	0.87	-2.52
Operating Profit After Depreciation	3.81	1.22	-2.17	1.15	-2.14

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	3.65	3.69	3.99	4.29	2.45
Total Non Current Assets	10.80	12.05	12.48	11.92	9.85
Total Current Assets	12.02	11.22	16.05	15.47	12.02
Total Assets	22.83	23.27	28.53	27.39	21.87
Total Shareholder's Fund	6.48	7.11	6.86	8.53	7.66

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	3.06	2.60	0.03	-0.44	-0.16
Net Cash Used In Investing Activities	0.46	-0.46	0.62	-0.87	-0.42
Net Cash Used In Financing Activities	-2.83	-4.08	-0.12	1.53	1.83

Particulars (in ₹ Cr.)	2021-09	2021-06	2020-09	2020-06	2020-03
Total Revenue	10.13	9.94	7.20	4.98	-
Total Expenses	9.59	8.31	7.09	5.38	-
Profit Before Tax	0.47	1.60	-0.01	-0.44	-
Profit After Tax	0.45	1.60	-0.02	-0.44	-0.57
Operating Profit after Depreciation	0.62	1.70	0.20	-0.33	-

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	12.93	10.85	12.32	12.68	13.30
Total Expenses	11.03	10.87	11.27	11.59	11.64
Profit Before Tax	1.79	-0.08	0.97	0.98	1.52
Profit After Tax	1.40	-0.04	-3.39	1.01	1.48
Operating Profit after Depreciation	1.96	0.07	1.14	1.16	1.74

Gujarat Terce Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 43.38

S2 42.46

S3 40.86

Pivot 44.98

R1 45.90

R2 47.50

R3 48.42

Moving Average

20 SMA 47.03

50 SMA 45.09

100 SMA 46.37

200 SMA 55.14

Gujarat Terce Laboratories Ltd Corporate Actions

No available data

AGM Date: 07 Sep 2021

AGM 07/09/2021 Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., on Thursday, 24th June, 2021 which commenced at 11:00 A.M. and concluded at 4:30 P.M inter alia, have approved the following: With reference to the Outcome of the Board Meeting held on June 24, 2021, Company had appointed Mr. Gautam Virsadiya, Practising Company Secretary, Ahmedabad as the Scrutinizer for the Annual General Meeting to be held on Tuesday, September 07, 2021, but due his some unavoidable personal commitments he has intimated us that he would not be able to continue as Scrutinizer for this AGM. Thereby, the Company has decided to appoint Mr. Ishan P. Shah, Advocate, Ahmedabad as the Scrutinizer of the Annual General Meeting to be held for the Financial Year 2020-21. We request you to kindly take this on your record and oblige. (As per BSE Announcement Dated on 5/8/2021) Pursuant to Regulation 30 of the Listing Regulations, we are submitting herewith the details regarding the proceedings of the 36th Annual General Meeting ('AGM') of the Company held on Tuesday, September 07, 2021 at 11:00 AM, but due to some technical issues the meeting commenced at 11:25 AM and concluded at 11:41 AM through Video Conferencing (VC)/ Other Audio Visual Means (OVAM). Kindly take the same on your records. (As per BSE Announcement Dated on 7/9/2021) Pursuant to regulation 44(3) of SEBI Listing Obligations and Disclosures Requirements (LODR) Regulations, 2015, please find enclosed herewith the details of voting results and scrutinizer's report for the Annual General Meeting conducted on Tuesday, 07th September, 2021 through video conferencing or other audio visual means. Kindly take the same on your records. Gujarat Terce Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 8/9/2021)

AGM Date: 24 Aug 2022

AGM 24/08/2022 Appointment of Mr. Ishan Shah, Practising Advocate as the Scrutinizer for the Thirty- Seventh Annual General Meeting of the Company. (As Per BSE Announcement Dated on 30/05/2022) Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, 18th August, 2022 to Wednesday, 24th August, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of Thirty-Seventh Annual General Meeting of the Company scheduled to be held on Wednesday, August 24th, 2022. (As Per BSE Announcement Dated on 31/05/2022) This is further to our letter dated August 01, 2022 and pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of proceedings of 37th Annual General Meeting of the Company held on August 24, 2022 through VC/OVAM. You are requested to kindly take above information on your records. (As Per BSE Announcement Dated on 24.08.2022) Pursuant to regulation 44(3) of SEBI Listing Obligations and Disclosures Requirements (LODR) Regulations, 2015, please find enclosed herewith the details of voting results and scrutinizer's report for the Annual General Meeting conducted on Wednesday, 24th August, 2022 through video conferencing or other audio visual means. Kindly take the same on your records. (As Per BSE Announcement Dated on 25.08.2022) Gujarat Terce Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 26.08.2022)

AGM Date: 25 Aug 2023

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 19th August, 2023 to Friday, 25th August, 2023 (both days inclusive) for taking record of the Members of the Company for annual closing and for the purpose of Thirty-Eighth Annual General Meeting of the Company scheduled to be held on Friday, 25th August, 2023. This is further to our letter dated August 01, 2023 and pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of proceedings of 38th Annual General Meeting of the Company held on August 25, 2023 through VC/OVAM. Details of voting results of 38th Annual General Meeting- Regulation 44(3) SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations'). (As per BSE Announcement Dated on 25/08/2023)

AGM Date: 17 Sep 2024

The Board has decided to call Annual General Meeting of the company for the financial year 2023-24 on Tuesday, 17th September, 2024 at 12:00 p.m. Annual Report of F.Y: 2023-24 is attached herewith (As Per BSE Announcement dated on 24.08.2024) Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the 39th AGM of the Company was held on 17th September, 2024, through Video conferencing and other audio-visual means and the business mentioned in the notice dated 24th August, 2024 was transacted. We enclose herewith a summary of proceedings of 39th Annual General Meeting of the Company. Kindly take the same on your record. (As Per BSE Announcement dated on 18.09.2024)

AGM Date: 21 Aug 2025

Outcome of Board Meeting held on 17th July, 2025. We are submitting herewith Annual Report (F.Y. 2024-25) along with Notice of AGM and Explanatory Statement thereto, which is being sent to members through electronic mode. Kindly take same on your records. (As Per BSE Announcement Dated on: 26/07/2025) Annual Report of F.Y: 2024-25 is attached herewith (As Per BSE Announcement Dated on :28.07.2025)

Gujarat Terce Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Gujarat Terce Laboratories Ltd Top Mutal Funds Invested

No data available

Gujarat Terce Laboratories Ltd News

Gujarat Terce Laboratories to announce Quarterly Result

On 8 November 2025

03 Nov 2025, 10:17 am

Gujarat Terce Laboratories to discuss results

On 11 August 2025

05 Aug 2025, 03:04 pm

Gujarat Terce Laboratories to convene AGM

On 21 August 2025

18 Jul 2025, 10:30 am

Gujarat Terce Laboratories schedules board meeting

On 17 July 2025

10 Jul 2025, 10:17 am

Gujarat Terce Laboratories to discuss results

On 26 May 2025

20 May 2025, 04:53 pm

Gujarat Terce Laboratories Ltd Stock Analysis

Annual revenue for Gujarat Terce Laboratories Ltd increased by 4.57% to ₹50.50 crore in FY 2025 from ₹48.30 crore in FY 2024.
Annual Net Profit for Gujarat Terce Laboratories Ltd decreased by 501.93% to ₹-0.98 crore in FY 2025 from ₹0.24 crore in FY 2024.
Promoter Shareholding in Gujarat Terce Laboratories Ltd remains unchanged by 0.00% in the most recent quarter, from 37.03% in June 2025 to 37.03% in September 2025.
Gujarat Terce Laboratories Ltd delivered a 1-year return of -45.04% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Gujarat Terce Laboratories Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹44.30. The latest Gujarat Terce Laboratories Ltd share price is INR ₹44.30.
Gujarat Terce Laboratories Ltd share price today has been at a low of 43.51 and a high of 44.30. Over the past 52 weeks, the Gujarat Terce Laboratories Ltd share price has seen a low of 37.20 and a high of 92.22.